| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-138 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-185 |
| filingDate |
2001-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f3e2b92bce71ff989c89bbae0544c5d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c307c2070f03844420f192ca7ff969fb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ffd06c8d200f8050812a4ad362bf560 |
| publicationDate |
2002-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2002065325-A1 |
| titleOfInvention |
Use of CLC3 chloride channel blockers to modulate vascular tone |
| abstract |
The present invention provides methods for the modulation of vascular tone in a patient having compromised vascular tissue, which methods comprise the administration of a chloride channel blocking agent or a pharmaceutically acceptable salt thereof. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017049178-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11060060-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020227344-A1 |
| priorityDate |
1999-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |